Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 | Market Research Report - PowerPoint PPT Presentation

About This Presentation
Title:

Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 | Market Research Report

Description:

Global Markets Directs, 'Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. For More Details: – PowerPoint PPT presentation

Number of Views:281

less

Transcript and Presenter's Notes

Title: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2013 | Market Research Report


1
(No Transcript)
2
Report Systemic Sclerosis (Scleroderma) -
Pipeline Review, H2 2013
Report Coverage
  • A snapshot of the global therapeutic scenario for
    Systemic Sclerosis (Scleroderma)
  • A review of the Scleroderma products under
    development by companies and universities or
    research institutes based on information derived
    from company and industry-specific sources
  • Coverage of products based on various stages of
    development ranging from discovery till
    registration stages
  • A feature on pipeline projects on the basis of
    monotherapy and combined therapeutics
  • Coverage of the Scleroderma pipeline on the basis
    of route of administration and molecule type

3
Report Systemic Sclerosis (Scleroderma) -
Pipeline Review, H2 2013
Report Coverage (Continued)
  • All discontinued pipeline projects
  • Latest news and deals related to the products

4
Report Systemic Sclerosis (Scleroderma) -
Pipeline Review, H2 2013
Report Benefits
  • Identify and understand diverse types of
    therapeutics under development for Scleroderma
  • Identify emerging players with potentially strong
    product portfolio
  • Design effective counter-strategies to gain
    competitive advantage
  • Plan mergers and acquisitions effectively by
    identifying players of the most promising
    pipeline
  • Devise corrective measures for pipeline projects
    by understanding Scleroderma pipeline depth and
    focus of indication therapeutics
  • Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope

5
Report Systemic Sclerosis (Scleroderma) -
Pipeline Review, H2 2013
Report Benefits (Continued)
  • Modify your therapeutic portfolio by identifying
    discontinued projects and understanding the
    factors that drove them from pipeline

6
Report Systemic Sclerosis (Scleroderma) -
Pipeline Review, H2 2013
Table of Contents
  • Introduction 
  • Overview
  • Comparative Analysis
  • RD Progress
  • Appendix 
  • Methodology

7
Report Systemic Sclerosis (Scleroderma) -
Pipeline Review, H2 2013
Report Details
  • Publish date 29th Oct, 2013
  • Number of slides 87
  • Geographic coverage Global
  • Available format PDF, CD, Hardcopy
  • Price for Single User License USD 2,000
  • Price for Site License USD 4,000
  • Price for Global User License USD 6,000
  • Delivery Time Within 1 business day
  • Payment Modes Credit/Debit Card, RTGS/Wire
    Transfer, Google Wallet, PayPal

8
Interested in this report?
To view more details regarding this premium
market research report, Please click here
For further information, get in touch with us
E-mail support_at_researchonglobalmarkets.com Call
US 1 866 325 7446 UK 44 203 514 2363 Others
91 22 4098 7600
About Us Research on Global Markets is a leading
source for market research on various sectors
globally offering premium research content from
worldwide publishers of market research reports
Industry Segments Industry Segments Industry Segments
Automotive Transport Consumer goods Agriculture
Food and Beverage Energy and Utilities Public Sector
Manufacturing Construction Healthcare Media Entertainment
IT, Telecom Electronics Services Others
Write a Comment
User Comments (0)
About PowerShow.com